Sarepta Therapeutics (SRPT) Q4 2023 Earnings Call Transcript

SRPT earnings call for the period ending December 31, 2023.

Related Keywords

United States ,Kristen Kluska ,Danielle Brill ,Gil Blum Needham ,Tazeen Ahmad ,Brian Skorney ,David Hoang ,Gil Blum ,Gena Wang ,William Blair ,Kostas Biliouris ,David Hoang Citi ,Ian Estepan ,Brian Abrahams ,Mille Cantor Fitzgerald ,Louise Rodino Klapac ,Joseph Schwartz ,Salveen Richter ,Anupam Rama ,Francesca Nolan ,America Merrill Lynch ,Neena Bitritto Garg ,Tim Lugo ,Gena Wang Barclays ,Morgan Stanley ,Doug Ingram ,Raymond James ,Rich Miller ,Tim Lugo William Blair ,Neena Bitritto Garg Deutsche Bank Analyst ,Barclays ,Citigroup ,Remarkable ,Goldman Sachs ,Cantor Fitzgerald ,Company Analyst ,Speak Foundation ,Novo Holdings ,Novo Nordisk ,Tazeen Ahmad Bank ,Deutsche Bank ,Corporate Communications ,Exchange Commission ,Sarepta Therapeutics ,Investor Relations ,Dallan Murray ,Motley Fool Stock Advisor ,Stock Advisor ,Chief Executive ,Sarepta Therapeutic ,Vice President ,Chief Commercial ,Chief Scientific ,Nature Medicine ,Ritu Baral ,Mike Ulz ,Mizuho Securities ,Duchenne Muscular Dystrophy ,Fourth Quarter ,Chief Executive Officer ,Senior Vice President ,Gene Therapy ,Chief Commercial Officer ,